AnaptysBio

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AnaptysBio and other ETFs, options, and stocks.

About ANAB

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab.

CEO

Daniel R. Faga

CEODaniel R. Faga

Employees

136

Employees136

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2005

Founded2005

Employees

136

Employees136

ANAB Key Statistics

Market cap

761.25M

Market cap761.25M

Price-Earnings ratio

-5.51

Price-Earnings ratio-5.51

Dividend yield

—

Dividend yield—

Average volume

521.17K

Average volume521.17K

High today

$26.92

High today$26.92

Low today

$25.84

Low today$25.84

Open price

$26.73

Open price$26.73

Volume

287.85K

Volume287.85K

52 Week high

$41.31

52 Week high$41.31

52 Week low

$12.21

52 Week low$12.21

ANAB News

Simply Wall St 3d

AnaptysBio, Inc.'s Share Price Not Quite Adding Up

With a median price-to-sales (or "P/S") ratio of close to 8.6x in the Biotechs industry in the United States, you could be forgiven for feeling indifferent abou...

Analyst ratings

83%

of 12 ratings

Buy

83.3%

Hold

16.7%

Sell

People also own

Based on the portfolios of people who own ANAB. This list is generated using Robinhood data, and it’s not a recommendation.